Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences
Axogen (NASDAQ: AXGN), a leader in peripheral nerve function surgical solutions, has announced its participation in four major upcoming investor conferences in September 2025. The company will host a fireside chat at the Cantor Global Healthcare Conference on September 3 at 3:20 PM ET, which will be available via webcast.
Management will also conduct one-on-one investor meetings at the Wells Fargo Healthcare Conference (September 4), Morgan Stanley Annual Global Healthcare Conference (September 10), and Lake Street BIG 9 Conference (September 11). All webcast events will be accessible through Axogen's investor relations website and archived for 90 days.
Axogen (NASDAQ: AXGN), leader nelle soluzioni chirurgiche per la funzione dei nervi periferici, ha annunciato la sua partecipazione a quattro importanti conferenze per investitori previste a settembre 2025. La società terrà un fireside chat al Cantor Global Healthcare Conference il 3 settembre alle 15:20 ET, disponibile in webcast.
La direzione svolgerà inoltre incontri one-on-one con gli investitori al Wells Fargo Healthcare Conference (4 settembre), al Morgan Stanley Annual Global Healthcare Conference (10 settembre) e al Lake Street BIG 9 Conference (11 settembre). Tutti i webcast saranno accessibili tramite il sito investor relations di Axogen e archiviati per 90 giorni.
Axogen (NASDAQ: AXGN), líder en soluciones quirúrgicas para la función de los nervios periféricos, ha anunciado su participación en cuatro importantes conferencias para inversores en septiembre de 2025. La compañía ofrecerá un fireside chat en el Cantor Global Healthcare Conference el 3 de septiembre a las 3:20 PM ET, disponible vía webcast.
La dirección también llevará a cabo reuniones individuales con inversores en el Wells Fargo Healthcare Conference (4 de septiembre), en el Morgan Stanley Annual Global Healthcare Conference (10 de septiembre) y en el Lake Street BIG 9 Conference (11 de septiembre). Todos los webcasts estarán disponibles a través del sitio de relaciones con inversores de Axogen y se archivarán durante 90 días.
Axogen (NASDAQ: AXGN), 말초신경 기능 수술 솔루션 분야의 선도 기업이 2025년 9월에 열리는 주요 투자자 컨퍼런스 네 곳에 참가한다고 발표했습니다. 회사는 Cantor Global Healthcare Conference에서 9월 3일 오후 3시 20분(ET)에 파이어사이드 채팅을 진행하며, 해당 세션은 웹캐스트로 제공됩니다.
경영진은 또한 Wells Fargo Healthcare Conference(9월 4일), Morgan Stanley Annual Global Healthcare Conference(9월 10일), Lake Street BIG 9 Conference(9월 11일)에서 일대일 투자자 미팅을 진행할 예정입니다. 모든 웹캐스트는 Axogen 투자자 관계 웹사이트를 통해 이용할 수 있으며 90일간 아카이브됩니다.
Axogen (NASDAQ: AXGN), leader des solutions chirurgicales pour la fonction des nerfs périphériques, a annoncé sa participation à quatre grandes conférences investisseurs en septembre 2025. La société animera un fireside chat au Cantor Global Healthcare Conference le 3 septembre à 15h20 ET, accessible en webcast.
La direction tiendra également des rencontres individuelles avec des investisseurs lors du Wells Fargo Healthcare Conference (4 septembre), du Morgan Stanley Annual Global Healthcare Conference (10 septembre) et du Lake Street BIG 9 Conference (11 septembre). Tous les webcasts seront disponibles via le site relations investisseurs d'Axogen et archivés pendant 90 jours.
Axogen (NASDAQ: AXGN), ein führendes Unternehmen für operative Lösungen zur Funktion peripherer Nerven, hat seine Teilnahme an vier wichtigen Investorenkonferenzen im September 2025 angekündigt. Das Unternehmen veranstaltet am 3. September um 15:20 Uhr ET ein Fireside-Chat beim Cantor Global Healthcare Conference, das per Webcast verfügbar sein wird.
Das Management wird zudem Einzelgespräche mit Investoren auf der Wells Fargo Healthcare Conference (4. September), der Morgan Stanley Annual Global Healthcare Conference (10. September) und der Lake Street BIG 9 Conference (11. September) führen. Alle Webcasts sind über die Investor-Relations-Website von Axogen zugänglich und werden für 90 Tage archiviert.
- None.
- None.
ALACHUA, Fla. and TAMPA, Fla., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that management is scheduled to participate in four upcoming investor conferences:
Cantor Global Healthcare Conference (NYC)
Participation: Fireside chat and 1x1 investor meetings
Date/Time: Fireside Chat Wednesday, September 3, 2025, 3:20 PM ET
Webcast Link: Cantor/Axogen Fireside Chat
Wells Fargo Healthcare Conference (Boston)
Participation: 1x1 investor meetings only
Date/Time: Thursday, September 4, 2025
Morgan Stanley Annual Global Healthcare Conference (NYC)
Participation: 1x1 investor meetings only
Date/Time: Wednesday, September 10, 2025
Lake Street Best Ideas Growth (BIG 9) Conference (NYC)
Participation: 1x1 investor meetings only
Date/Time: Thursday, September 11, 2025
Webcast events can be accessed live through the Investors page at www.axogeninc.com. For those not available to listen to the live broadcast, the replay will be archived for 90 days and available through the Investors page on www.axogeninc.com.
About Axogen
Axogen (AXGN) is the leading Company focused specifically on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. Axogen employees are passionate about helping to restore peripheral nerve function and quality of life to patients with physical damage or transection to peripheral nerves by providing innovative, clinically proven, and economically effective repair solutions for surgeons and health care providers. Peripheral nerves provide the pathways for both motor and sensory signals throughout the body. Every day, people suffer traumatic injuries or undergo surgical procedures that impact the function of their peripheral nerves. Physical damage to a peripheral nerve, or the inability to properly reconnect peripheral nerves, can result in the loss of muscle or organ function, the loss of sensory feeling, or the initiation of pain.
Axogen’s product portfolio includes Avance® Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; Axoguard Nerve Connector®, a porcine (pig) submucosa extracellular matrix (“ECM”) coaptation aid for tensionless repair of severed peripheral nerves; Axoguard Nerve Protector®, a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while minimizing soft tissue attachments; Axoguard HA+ Nerve Protector™, a porcine submucosa ECM base layer coated with a proprietary hyaluronate-alginate gel, a next-generation technology designed to enhance nerve gliding and provide short- and long-term protection for peripheral nerve injuries; Axoguard Nerve Cap®, a porcine submucosa ECM product used to protect a peripheral nerve end and separate the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and Avive+ Soft Tissue Matrix™, a multi-layer amniotic membrane allograft used to protect and separate tissues in the surgical bed during the critical phase of tissue healing. The Axogen portfolio of products is available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea and several other countries.
For more information, visit www.axogeninc.com
Contact:
Axogen, Inc.
InvestorRelations@axogeninc.com
FAQ
When is Axogen's (AXGN) fireside chat at the Cantor Global Healthcare Conference 2025?
Which investor conferences will Axogen (AXGN) attend in September 2025?
How can investors access Axogen's (AXGN) conference presentations?
What type of meetings will Axogen (AXGN) conduct at the Wells Fargo Healthcare Conference?
